Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community

Kotsiou, Ourania S.; Papagiannis, Dimitrios; Fradelos, Evangelos C.; Siachpazidou, Dimitra I.; Perlepe, Garifallia; Miziou, Angeliki; Kyritsis, Athanasios; Vavougios, George D.; Kalantzis, Georgios; Gourgoulianis, Konstantinos I.

doi:10.3390/ijerph19010407

Submit to this Journal Review for this Journal Edit a Special Issue

Article Menu

...

Open AccessArticle

Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community

Ourania S. Kotsiou

^1,2,*

Dimitrios Papagiannis

Evangelos C. Fradelos

Dimitra I. Siachpazidou

²,

²,

²,

² and

Konstantinos I. Gourgoulianis

Faculty of Nursing, School of Health Sciences, University of Thessaly, Gaiopolis, 41110 Larissa, Greece

Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41110 Larissa, Greece

Public Health & Vaccines Lab, Department of Nursing, School of Health Sciences, University of Thessaly, Gaiopolis, 41110 Larissa, Greece

Author to whom correspondence should be addressed.

Academic Editors: Riccardo Polosa, Pietro Ferrara, Luciana Albano and Venera Tomaselli

Int. J. Environ. Res. Public Health 2022, 19(1), 407; https://doi.org/10.3390/ijerph19010407

Received: 27 November 2021 / Revised: 24 December 2021 / Accepted: 28 December 2021 / Published: 31 December 2021

(This article belongs to the Special Issue A Public Health View on COVID-19: Epidemiology, Implications and Responses)

View Full-Text Download PDF

Browse Figures

Review Reports Citation Export

Abstract

Background: In this work, we aimed to evaluate antibody-response longevity to SARS-CoV-2 infection and/or vaccination in one of the Greek communities that was worst hit by the pandemic, Deskati, five months after a previous serosurveillance and nine months after the pandemic wave initiation (October 2020). Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. Results: A total of 69 subjects, who previously tested positive or negative for COVID-19 antibodies, participated in the study. We found that 48% of participants turned positive due to vaccination. 27% of participants were both previously infected and vaccinated. However, all previously infected participants retained antibodies to the virus, irrespective of their vaccination status. The antibody titers were significantly higher in previously infected participants that had been vaccinated than those who were unvaccinated and in those that had been previously hospitalized for COVID-19 than those with mild disease. Conclusions: Antibody responses to SARS-CoV-2 infection were maintained nine months after the pandemic. Vaccination alone had generated an immune response in almost half of the population. Higher antibody titers were found in the case of vaccination in previously infected subjects and especially in those with severe disease leading to hospitalization. View Full-Text

Keywords: antibody testing; Greece; semi-closed community; seroprevalence

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Share and Cite

MDPI and ACS Style

Kotsiou, O.S.; Papagiannis, D.; Fradelos, E.C.; Siachpazidou, D.I.; Perlepe, G.; Miziou, A.; Kyritsis, A.; Vavougios, G.D.; Kalantzis, G.; Gourgoulianis, K.I. Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community. Int. J. Environ. Res. Public Health 2022, 19, 407. https://doi.org/10.3390/ijerph19010407

AMA Style

Kotsiou OS, Papagiannis D, Fradelos EC, Siachpazidou DI, Perlepe G, Miziou A, Kyritsis A, Vavougios GD, Kalantzis G, Gourgoulianis KI. Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community. International Journal of Environmental Research and Public Health. 2022; 19(1):407. https://doi.org/10.3390/ijerph19010407

Chicago/Turabian Style

Kotsiou, Ourania S., Dimitrios Papagiannis, Evangelos C. Fradelos, Dimitra I. Siachpazidou, Garifallia Perlepe, Angeliki Miziou, Athanasios Kyritsis, George D. Vavougios, Georgios Kalantzis, and Konstantinos I. Gourgoulianis. 2022. "Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community" International Journal of Environmental Research and Public Health 19, no. 1: 407. https://doi.org/10.3390/ijerph19010407

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI